跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EMAZOLE POWDER FOR SOLUTION FOR INJECTION/INFUSION 40MG/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
EMAZOLE POWDER FOR SOLUTION FOR INJECTION/INFUSION 40MG/VIAL
Approved
THERAPEUTIC
EMAZOLE POWDER FOR SOLUTION FOR INJECTION/INFUSION 40MG/VIAL
STANDARD CHEM. & PHARM. CO. LTD (TAIWAN)
🇸🇬 Health Sciences Authority
Approval Date
Jun 6, 2018
Approval ID
d371252e6d3059c7
Company
STANDARD CHEM. & PHARM. CO. LTD (TAIWAN)
Type
Therapeutic
Approval Details
Approval Id
d371252e6d3059c7
Drug Name
EMAZOLE POWDER FOR SOLUTION FOR INJECTION/INFUSION 40MG/VIAL
Product Name
EMAZOLE POWDER FOR SOLUTION FOR INJECTION/INFUSION 40MG/VIAL
Approval Number
SIN15500P
Approval Date
2018-06-06
Registrant
PFIZER PRIVATE LIMITED
Licence Holder
PFIZER PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
A02BC05
Atc Item Name
esomeprazole
Pharma Manufacturer Name
PFIZER PRIVATE LIMITED
Company Detail Path
/organization/pfizer-private-limited
Active Ingredients
Esomeprazole Sodium 42.56mg eqv to Esomeprazole
40 mg
ESOMEPRAZOLE SODIUM 42.56 MG EQV TO ESOMEPRAZOLE
40 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 6, 2018
Approval ID
d371252e6d3059c7
Type
Therapeutic
Back to HSA Approvals
